Member Info for rickmeister

Hardly news I know but the following from Sky News. Small restaurants complain about high commissions from Deliveroo and Just Eat-up to 35%. 'Small restaurants are accusing Deliveroo of unfairness and claim the delivery app is charging some large chain restaurants significantly lower commission rates than many small independent partners'.

I thought Trumps remedy of choice was Domestos!!

Alwaysone. If you are right about the ipo figure for STEM, circa £300m and it transfers for £3m ( which I equate to approx 1.5p/share) then after the ipo each share will be worth £1.50/share. Time to stock up!!!!! I would be careful about quoting an ipo value unless you have knowledge the rest of us don't. I appreciate its an opinion but others might read it differently. Fingers crossed.

The only figure applied to STEM is circa £3m which is the cost to date to TILS of developing the technology. It will be transferred into a new co at this figure, but this is not necessarily what it is worth, that will be determined by the market on flotation. I have no doubt the DoB have a view of what STEM is worth but haven't said openly what that might be. I assume before the float/IPO a value will be indicated as is the case for most IPOs.

For info, thought people in this share might like to see BD's post on the SAE board this morning. Leave you to make your own minds up as to his motives for his posts here today:
Yeah same mate I need to get to 32.p just to break even l. Here for the long term tho. Think big-

That might be too much to expect but a blue day looks v likely. Edging closer to the cut off date to be holding shares for the demerger.

yes

Looks like Nas will open up a bit today. Perhaps peops have got bored of this share and posting!

Almost certainly what they have spent on Stem to date. It is perfectly legit to value an asset for accounting purposes at cost. The risk is that if it is not regularly re-valued and suddenly has a massive increase in value it will show up in the P&L and will give rise to a tax liability. I assume that was what the company was checking. Once it is in another company the 'profit' will occur in that company.

See note from RNS below. Book value £3m. This is not necessarily its MV which will be established by an IPO. Divi in Specie is a divi in value not cash. As far as I am aware the BoD have not given an opinion of MV from Stem

The Demerger will be implemented by Tiziana declaring a dividend in specie on the Tiziana Shares equal to the book value (of approximately £3.07m) of Tiziana's shareholding in StemPrintER Sciences, the entity within the Tiziana group which holds all of the assets and intellectual property relating to StemPrintER and SPARE and £1.0 million in cash.

Hindsight is a great asset, could easily have gone the other way. The future of this company s mapped out but the markets are having a field day.

Calling it short selling is just a cover for market manipulation. If a firm is deliberately managing an SP to its own or client's advantage it is sharp practice. Years ago Guinness and its CEO, a fellow called Saunders, were found guilty of market manipulation and its still going on. Its no better than a cartel in other industries. Should be banned.

Moved up nicely in Sweden, 6.47p equivalent

Var ar Pocko?

Dummy sell at 5.155, better than it has been.

But it ramps up the pressure on the Government, keeping the environmental argument at the forefront. A very useful RNS, in my opinion.

Yep, had the DVLA one recently-delete immediately. HMRC scams are a regular event.

The Septics are either clever or slow. Answers on a postcard!

Been offered 5.5p to buy for the last 3 days, tried kill or fill just below but nothing doing. 5.5 is about where the Swedes are based on current exchange rate. Has the feel of the calm before the storm, I hope.

Since the highs a month ago he has lost over £80m. Can't have sold any as he has to declare if he deals in any amount. Only he and the BoD should know what's going on-can't see they have done any of the key investors any favours with this drop. TILS has been under attack ever since the ADS ratio change and the placing. It looks like very poor management but GC does have a good record with small pharma companies so assuming he does have a plan, lets hope it unveils soon as credibility is on the line now.